Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

GT Biopharma Inc 505 Montgomery Street 10th Floor San Francisco CA 94111 USA

www.gtbiopharma.com Employees: 1 P: 800-304-9888

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

GT Biopharma Inc. is an immuno-oncology company. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. GT Biopharma Inc., formerly known as OXIS International Inc., is based in Tampa, Florida.

Key Statistics

Overview:

Market Capitalization, $K 7,932
Enterprise Value, $K 3,892
Shares Outstanding, K 10,636
Float, K 10,274
% Float 96.60%
Short Interest, K 2,111
Short Float 19.84%
Days to Cover 1.00
Short Volume Ratio 0.33
% of Insider Shareholders 3.40%
% of Institutional Shareholders 8.15%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -13,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,110 K
EBIT, $ -10,580 K
EBITDA, $ -10,580 K

Growth:

1-Year Return -69.65%
3-Year Return -97.36%
5-Year Return -99.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 11/14/25
Next Earnings Date 02/20/26
Earnings Per Share ttm -3.80
EPS Growth vs. Prev Qtr -50.91%
EPS Growth vs. Prev Year 45.75%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/05/24

GTBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,258.75%
Return-on-Assets % -220.17%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.50
Book Value/Share 0.50
Interest Coverage -0.54
60-Month Beta 1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar